Lists of previous medicines annexed to this Circular include the followings:
- List of 214 medicines used for prevention, diagnosis and treatment of rare diseases, specifically including:
+ Acalabrutinib prescribed for treatment of mantle cell lymphoma;
+ Bedaquilin prescribed for treatment of active tuberculosis;
+ Bleomycin sulfate prescribed for treatment of benign pleural effusion;
- List of 229 medicines not ready for use, specifically including:
+ Chemical medicines and biologicals: Acid folic (Mono) (Vitamin B9); positive histamine control used in skin prick tests; Vinblastin;…
+ Radiopharmaceuticals and tracers: Carbon 11 (C-11); Cobalt 57 (Co-57); Phosphorus 32 (P-32); Urea (NH2 14CoNH2);…
+ Vaccines: Yellow fever vaccine (living 17D-204 strain of yellow fever virus with reduced toxicity).
For more details, please read the Circular No. 26/2019/TT-BYT (entering into force on October 15, 2019).
>> CLICK HERE TO READ THE ARTICLE IN VIETNAMESE
979